Braves face a full-season void as Jurickson Profar’s 162-game suspension is upheld
The Braves learned Thursday that Jurickson Profar’s appeal failed, locking in a 162-game suspension that will wipe out his entire 2026 season and make him ineligible for postseason play if Atlanta qualifies. The ruling also means Profar must forfeit his $15 million salary for the season, turning an already difficult situation into a hard deadline for roster planning.
What happened with the Braves and Jurickson Profar’s suspension?
Major League Baseball suspended Profar on March 3 after a positive test for exogenous testosterone. It was his second positive test for a performance-enhancing drug in a little more than 12 months. He appealed the latest discipline, but the suspension was upheld Thursday, ending the uncertainty over whether any portion of the penalty might be reduced.
The consequence is sweeping: Profar will miss all of the 2026 regular season. He also cannot participate in the 2026 postseason. For a club trying to balance immediate competitiveness with long-term commitments, the timing leaves little room for half-measures.
How does the suspension change Atlanta’s money, payroll, and options?
The suspension reshapes the Braves’ ledger as much as it changes their lineup. Profar will not be paid his $15 million salary this season, and Atlanta will be spared the $3 million in luxury taxes it would have paid on his contract, a combined $18 million swing tied directly to his absence. Whether the club intends to reinvest any of that savings remains unresolved, and there has been little indication the team is actively seeking external additions at this point.
The financial context matters because Atlanta was already pushing a franchise-record payroll at the time of Profar’s suspension. That reality has hovered over every subsequent decision: how aggressive to be, how quickly to act, and whether to treat the savings as an opportunity or as a cushion.
On the field, the challenge is not limited to replacing one player. This spring, three injuries in the rotation added pressure to the team’s depth chart: Spencer Schwellenbach and Hurston Waldrep both had loose bodies removed from their right elbows, and left-hander Joey Wentz was lost for the season due to an ACL tear. Those developments, paired with the loss of Profar, shape a roster puzzle that demands both creativity and restraint.
In terms of alternatives, the list of notable free agents the Braves could consider has been described as thin, though right-hander Lucas Giolito is one exception mentioned in discussions of potential fits. Left-hander Tyler Anderson remains unsigned. Another pathway is lower-cost: veterans around the league who have the right to opt out of minor league contracts over the next week. Those players would not command significant money, but they expand the menu of choices if Atlanta’s baseball operations group decides it needs reinforcement.
What does this mean for Profar’s future and the contract through 2027?
Profar is still under contract with Atlanta through 2027, when he would be owed $15 million in the final season of a three-year, $42 million deal. The agreement was signed in January 2025 after an All-Star season with San Diego in 2024, but his time in Atlanta has been brief: Profar has played just 80 games for the Braves.
His discipline history is now central to how the organization will think about the remaining commitment. In 2025, Profar served an 80-game suspension after testing positive for human chorionic gonadotropin, losing more than $5. 1 million in salary for missing nearly half the campaign. With the 2026 suspension tied to exogenous testosterone and upheld in full, his status becomes less a short-term question and more an organizational one—what to do with a player who will spend the entire 2026 season on the restricted list.
It is not yet clear how the Braves will proceed with Profar beyond this suspension, and there is no urgency to resolve it immediately because of the restricted-list placement. Still, the stakes rise if any further violations occur: with two PED suspensions, Profar is now one positive test away from becoming just the second player to receive a lifetime ban following three positive PED tests, a distinction currently held by right-hander Jenrry Mejia.
In the end, the Braves are left with a stark reality: a player signed to help stabilize the roster will not take the field at all in 2026, and the organization must decide what “replacing” him truly means—spending the $18 million swing, finding value on the margins, or absorbing the loss and moving forward. For now, the only certainty is the absence created by braves plans colliding with an upheld 162-game suspension.
